FOXA1 overexpression has been implicated in genome‐wide enhancer reprogramming and expansion in tumours,119 such as in ER+ breast cancer, where FOXA1‐mediated activation of a HIF‐α super‐enhancer activates a pro‐metastatic transcription program.120. Here, FOXA1 is linked to breast cancer.